The Complement-based Drug Development Summit Boston, Massachusetts, USA 14-16 November 2017

Description:
The Complement-based Drug Development Summit is the first industry-dedicated meeting that focuses on the research and development of therapeutics to inhibit the complement pathway, providing safe and effective cures for a range of disease indications.

Across 3 content-packed days, the field's thought leaders from Alexion, True North, GSK, Alnylam and many more will be sharing their insight and lessons learned, collectively enabling the community to:

URLs:
Booking: https://go.evvnt.com/140307-3
Tickets: https://go.evvnt.com/140307-4

Price
Industry Conference Standard: USD 2699,
Academic Conference Standard: USD 1889,
Industry Gold: Conference and 2 workshops: USD 3797,
Academic Gold: Conference and 2 workshops: USD 2658,
Industry Silver: Conference and 1 workshop: USD 3298,
Academic Silver: Conference and 1 workshop: USD 2310,
Academic Workshop Only: USD 699,
Industry Workshop Only: USD 699

Speakers: Ted Yednock, Michael Holers, Camille Bedrosian, Eva-Maria Nichols, Sandip Panicker, Nader Najafian, Cedric Francois, Michael McCaleb, Niels Riedemann, Ashley Frazer-Abel, Kishor Devalaraja, David Apelian, Sacha Zeerleder, Christopher Horvath, Menno van Beek, Rajendra Kumar-Singh, Jörg Köhl, Kourous Rezaei

Time: 8:00 am to 6:00 pm